Heldal Kristian, Leivestad Torbjørn, Hartmann Anders, Svendsen Martin Veel, Lien Bjørn Herman, Midtvedt Karsten
Section of Nephrology and Endocrinology, Clinic of Internal Medicine, Sykehuset Telemark HF, 3710 Skien, Norway.
Nephrol Dial Transplant. 2008 Mar;23(3):1026-31. doi: 10.1093/ndt/gfm719. Epub 2007 Dec 13.
Elderly patients are the fastest growing population requiring renal replacement therapy. With increasing scarcity of organs, old patients are likely to remain in dialysis. We have had an active transplant program with elderly patients (i.e. > or = 70 years) and present results from our experiences.
From 1990 throughout 2005, we performed 301 first kidney transplantations in elderly patients. Data were compared with 513 senior patients aged 60-69 years and 512 control patients, aged 45-54 years, transplanted during the same time period. Time in dialysis prior to transplantation, number of patients receiving a living donor (LD) kidney, donor age, HLA mismatch, rejections, patient- and graft survival data were collected.
The 5-year actuarial patient survival was 56% in elderly patients, 72% in senior patients; P < 0.001 versus elderly and 91% in control patients; P < 0.001 versus elderly. Death censored graft survival was similar in the different groups, 89% in elderly, 88% in senior and 90% in control patients. LD was used in 35%; 17% in elderly patients, 34% in senior patients; P < 0.001 and 47% in control patients; P < 0.001. Pre-emptive transplantation was performed in 19% of the patients; 10% in elderly patients, 18% in senior patients; P = 0.003 and 25% in control patients; P < 0.001.
Our data show no difference in death censored graft survival between the age groups. Given the poor prognosis during dialysis treatment, selected elderly patients may successfully be offered a kidney transplant.
老年患者是需要肾脏替代治疗的人群中增长最快的群体。随着器官日益稀缺,老年患者可能会继续接受透析治疗。我们开展了一项针对老年患者(即年龄≥70岁)的积极移植项目,并展示我们的经验结果。
从1990年至2005年,我们对老年患者进行了301例首次肾脏移植。将数据与同期进行移植的513例60 - 69岁的老年患者以及512例45 - 54岁的对照患者进行比较。收集移植前透析时间、接受活体供肾(LD)的患者数量、供体年龄、HLA错配、排斥反应、患者及移植物存活数据。
老年患者5年精算患者生存率为56%,老年患者为72%;与老年患者相比P < 0.001,对照患者为91%;与老年患者相比P < 0.001。不同组间死亡截断移植物存活率相似,老年患者为89%,老年患者为88%,对照患者为90%。35%使用了活体供肾;老年患者为17%,老年患者为34%;P < 0.001,对照患者为47%;P <